MicroRNAs expression profiles in cardiovascular diseases.
about
Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and ApoptosisNovel epigenetic-based therapies useful in cardiovascular medicineMicroRNA-143/-145 in Cardiovascular DiseasesEpigenetic mechanisms in heart development and diseasePaving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis.Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer PatientsCould lncRNAs be the missing links in control of mesenchymal stem cell differentiation?MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort.The ACE2/Apelin Signaling, MicroRNAs, and Hypertension.MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction PatientsHeart Failure in Chronic Myocarditis: A Role for microRNAs?Sirtuins, aging, and cardiovascular risks.Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery DiseaseRheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides.Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease.MicroRNAs Associated with Shoulder Tendon Matrisome Disorganization in Glenohumeral ArthritismiRNA 206 and miRNA 574-5p are highly expression in coronary artery disease.Cross-Tissue Regulatory Gene Networks in Coronary Artery DiseaseRole of miRNAs in Epicardial Adipose Tissue in CAD Patients with T2DM.Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.The role of microRNAs in equine medicine: a review.Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.An integrated approach to coronary heart disease diagnosis and clinical management.Circulating microRNAs in acute and chronic exercise: more than mere biomarkers.Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.Exosomes in Cardiovascular Medicine.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.Circadian MicroRNAs in Cardioprotection.A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers.Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance.Serum MicroRNA-27b as a Screening Biomarker for Left Ventricular Hypertrophy.Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.Independent and combined effects of environmental factors and miR-126, miR-143, and miR-145 on the risk of coronary heart disease.Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death.Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome.
P2860
Q26746965-C8A8714D-0B8E-4C30-BC70-A0473BA9FDF0Q26765152-6F2A3BAC-AD01-4B81-AC78-50E0852BF854Q26801892-A0086FD5-AC81-4B42-9C8E-6E84D282D9ABQ28081134-CE14B422-F960-4D2D-8D89-D326D59F1ABDQ31004210-F5459036-BA3E-4B2F-A6A0-93D226AECD67Q33765415-F868D535-C137-4F7A-BA93-8E24FE1F39C4Q33816471-10D1EF94-C451-4FD4-8D7B-D254B0100329Q34584549-423288E4-39FA-4C79-9DC0-7DC9492BE1FEQ35137663-9C8D7330-5CC4-48F9-AEBD-011922D108B3Q35178127-AF16DFA4-E0E1-483E-8E72-1CA6CAFF7A92Q35653724-5D472677-D1A8-4B3F-B4AE-6A63CB46D3E4Q35742151-CB3009FA-1E53-461B-B827-B05EB3817EE3Q35768345-DC68EDCD-0CB4-4AAC-8F7C-041D8239F669Q35814157-620DB8F6-7BDC-45F9-936B-7AB1672EDA9EQ35882504-F3535C62-E2EF-4C3B-AE2D-7FA8EE9013CFQ35979145-39FDD4B2-5C6C-48D2-A275-A51B5958C768Q36134715-E7C37AC1-558A-46DA-8EF9-11F6C32B1556Q36228480-3F99A40B-D12B-45E5-A470-D6B45D087056Q36565304-33D193CA-7FE1-49D7-BD95-0267074F8EFEQ36865220-6CD0BEAA-E01E-44E4-B5C7-A79FBFDF43D1Q37212231-91620DF5-8335-4901-AB49-C3E9355AC58BQ37432623-BFAFFD2F-D884-4185-84CD-31D3CB974963Q38361340-5DFCC4DA-FDBA-46AB-A55F-2E4305327A6BQ38459113-3B4C88E5-8987-4F2B-9F1A-0564D67559B1Q38626596-E439E266-BCB3-464C-81FE-2D4A598762EDQ38776396-B7D868D5-7AF3-4113-9F96-66A37B09E28EQ38840533-C4099F7E-1030-4F9A-B947-84FF5B0DA309Q39319239-7A891944-F129-4B4B-90C6-0099F40B965DQ39403789-0F67353C-4F4E-43F2-828D-048C1A7DDFF4Q39430271-5A4375EE-CDEC-4242-9AB4-092A178129CFQ39621874-80FC115B-0FC2-4253-8C06-FA46B9BCD48BQ42316109-7E21308A-BED6-4535-B734-E1B93DA183CCQ46773662-2712A40B-53EB-48C1-A601-9166CFA5B0B4Q47138758-5D7CE6B3-46D2-484E-A5BD-A16C33A3F9C2Q47335450-BFFCDF3C-E73E-4DA0-A6C7-7D1B7F825146Q47658809-3F98198D-E35E-4867-ACD6-FC0E38A6BD8DQ49574372-36F14769-8D35-497F-8B1E-9A537A5D25CAQ54959799-638B3575-D698-4720-9A85-0C8464C9B0A4
P2860
MicroRNAs expression profiles in cardiovascular diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNAs expression profiles in cardiovascular diseases.
@ast
MicroRNAs expression profiles in cardiovascular diseases.
@en
type
label
MicroRNAs expression profiles in cardiovascular diseases.
@ast
MicroRNAs expression profiles in cardiovascular diseases.
@en
prefLabel
MicroRNAs expression profiles in cardiovascular diseases.
@ast
MicroRNAs expression profiles in cardiovascular diseases.
@en
P2860
P921
P356
P1476
MicroRNAs expression profiles in cardiovascular diseases.
@en
P2093
Elsa Bronze-da-Rocha
P2860
P304
P356
10.1155/2014/985408
P407
P5008
P577
2014-06-12T00:00:00Z